Patents by Inventor Eileen P. Kelly

Eileen P. Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA or RNA encoding a recombinant dengue envelope protein
    Patent number: 7265215
    Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: September 4, 2007
    Assignee: United States of America as Represented by the Secretary of the Army
    Inventors: Eileen P. Kelly, Alan D. King
  • Recombinant vaccine against dengue virus
    Publication number: 20040022811
    Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
    Type: Application
    Filed: February 3, 2003
    Publication date: February 5, 2004
    Inventors: Eileen P. Kelly, Alan D. King
  • Recombinant vaccine against dengue virus
    Patent number: 6514501
    Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: February 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Eileen P. Kelly, Alan D. King
  • Recombinant dengue virus DNA fragment
    Patent number: 6074865
    Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
    Type: Grant
    Filed: July 20, 1995
    Date of Patent: June 13, 2000
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Eileen P. Kelly, Alan D. King